Indian journal of Medical Biochemistry

Register      Login

VOLUME 23 , ISSUE 1 ( January-April, 2019 ) > List of Articles

RESEARCH ARTICLE

Prevalence of Prediabetes at the Tertiary Healthcare Center, McGann Teaching District Hospital, Shivamogga, Karnataka, India

Gurupadappa K, Geetha Bhaktha, Manjula B, Parameshwara, Prashanth S

Keywords : Combined, Isolated impaired fasting glucose, Prediabetic

Citation Information : K G, Bhaktha G, B M, P, S P. Prevalence of Prediabetes at the Tertiary Healthcare Center, McGann Teaching District Hospital, Shivamogga, Karnataka, India. Indian J Med Biochem 2019; 23 (1):213-216.

DOI: 10.5005/jp-journals-10054-0088

License: CC BY-NC 4.0

Published Online: 01-04-2019

Copyright Statement:  Copyright © 2019; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Aim: The aim of this study was to assess the prevalence of prediabetic state among the people with no clinical symptoms of hyperglycemia and factors underlying the risk of prediabetes. Materials and methods: Patients visiting medicine outpatient department (OPD) were recruited for the study at the tertiary healthcare center, McGann Teaching District Hospital, Shivamogga. Data regarding the health-related status and other risk factors were collected between May 2016 and April 2017. In this cross-sectional study, factors related to the risk of diabetes were analyzed and tabulated. Results: The prevalence of prediabetes was 0.17%, out of which 36.36 % were male, and 63.64% were females, respectively. Participants had a mean age of 47.45 ± 9.95 years, with a higher percentage of people under IFG (39%). The average BMI was 24.44 ± 3.89 with more percent of subjects in impaired fasting glucose (IFG) are having a BMI 25–29.9. Conclusion: Future intervention should include strategies to address social isolation and also focus on middle-aged subjects with the low socioeconomic state. Knowledge enhancement program is warranted for the prevention of prediabetes in this population.


PDF Share
  1. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1052.
  2. Shah C, Sheth NR, Solanki B, et al. To assess the prevalence of impaired glucose tolerance and impaired fasting glucose in Western Indian population. J Assoc Physicians India 2013;61(3):179-184.
  3. Zimmet PZ. Diabetes epidemiology as a tool to trigger diabetes research and care. Diabetogia 1999; 42:499-518.
  4. Anjana RM, Deepa M, Pradeepa R, et al. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol 2017; 5(8):585-596.
  5. Rao CR, Kamath VG, Shetty A, et al. A study on the prevalence of type 2 diabetes in costal Karnataka. Int J Diabetes Dev Ctries 2010; 30:80-85.
  6. Diagnosis and Classification of Diabetes Mellitus. American Diabetes Association. Diabetes Care Jan 2014;37(1):S81-S90.
  7. Nathan DM, Davidson MB, DeFronzo RA, et al. American Diabetes Association. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007; 30(3):753-759.
  8. Qiao Q, Hu G, Tuomilehto J, DECODA Study Group, et al. Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care 2003; 26(6):1770-1780.
  9. Ding EL, Song Y, Manson JE, et al. Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study. Diabetologia 2007; 50(10):2076-2084.
  10. Krishnan S, Rosenberg L, Djoussé L, et al. Overall and central obesity and risk of type 2 diabetes in U.S. black women. Obesity (Silver Spring) 2007;15(7):1860-1866.
  11. Abdul-Ghani MA, Jenkinson CP, Richardson DK, et al. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes 2006;55(5): 1430-1435.
  12. Weyer C, Bogardus C, Pratley RE. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 1999;48:2197-2203.
  13. Wasada T, Kuroki H, Katsumori K, et al. Who are more insulin resistant, people with IFG or people with IGT? Diabetologia 2004;47: 758-759.
  14. Hanefeld M, Koehler C, Fuecker K, et al. The Impaired Glucose Tolerance for Atherosclerosis and Diabetes study: Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. Diabetes Care 2003;26:868-874.
  15. Festa A, D'Agostino R Jr, Hanley AJ, et al. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes 2004;53:1549-1555.
  16. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998; 21(4):518-524.
  17. Snehalatha C, Ramchandran A, Kapur A, et al. Age-specific prevalence and risk associations for impaired glucose tolerance in urban southern Indian population. J Assoc Physicians India 2003; 51:766-769.
  18. Pandey U, Midha T, Rao YK, Katiyar P, et al. Anthropometric indicators as predictor of pre-diabetes in Indian adolescents. Indian Heart Journal 2017;69(4):474-479.
  19. Ganz ML, Wintfeld N, Li Q, et al. The association of body mass index with the risk of type 2 diabetes: a case-control study nested in an electronic health records system in the United States. Diabetol Metab Syndr 2014;6(1):50.
  20. Rahmanian K, Shojaei M, Jahromi AS, et al. The association between pre-diabetes with Body Mass Index and marital status in an Iranian urban population. Glob J Health Sci 2016;8(4):95-101.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.